SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001607062-14-000138
Filing Date
2014-10-17
Accepted
2014-10-17 16:23:09
Documents
4
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A gnbt20141014form10ka.htm 10-K/A 378254
2 EXHIBIT 31.1 gnbt20141014form10kaex31_1.htm EX-31.1 16431
3 EXHIBIT 31.2 gnbt20141014form10kaex31_2.htm EX-31.2 16425
4 EXHIBIT 32 gnbt20141014form10kaex32.htm EX-32 7168
  Complete submission text file 0001607062-14-000138.txt   419314
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: 10-K/A | Act: 34 | File No.: 000-25169 | Film No.: 141162121
SIC: 2834 Pharmaceutical Preparations